Colorado Capital Management, Inc. Catalyst Biosciences, Inc. Transaction History

Colorado Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Jan 17, 2023	BUY	$0.49 - $0.57 $10,021 - $11,658	20,453 Added 149.16%	34,165 $18,000
Q1 2020 May 08, 2020	BUY	$3.5 - $8.51 $47,992 - $116,689	13,712 New	13,712 $59,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Colorado Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Colorado Capital Management, Inc. with notifications on news.